Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 1, 2001, Pages 13-19

  Langman, M J S ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; DICLOFENAC; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ADULT; AGED; ARTICLE; BLEEDING; CALCULATION; CHEMOPROPHYLAXIS; DATA ANALYSIS; DEATH; DRUG SAFETY; DRUG USE; HOSPITAL ADMISSION; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; PEPTIC ULCER; PRIORITY JOURNAL; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; COST OF ILLNESS; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; INTESTINE, SMALL; MALE; ODDS RATIO; PEPTIC ULCER HEMORRHAGE; PEPTIC ULCER PERFORATION; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; WALES;

EID: 0035036271     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.561     Document Type: Article

References (21)

1. Hill AB. A Short Textbook of Medical Statistics. Hodder & Stoughton: London; 1977.
2. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078.
3. Garcia-Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
4. Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53: 485-494.
5. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arth Rheum 1993; 36: 84-90.
6. Laporte JR, Carne X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 85-98.
7. Griffin MR, Piper JM. Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-263.
8. Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991; 32: 730-734.
9. Nobili A, Mosconi P, Franzosi MG, Tongnoni G. Non-steroidal antiinflammatory drugs and gastrointestinal bleeding, a post-marketing surveillance case-control study Pharmacoepidemiol Drug Safe 1992; 1: 65-72.
10. Carson JL, Strom BL, Morse ML, et al. The relative toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987; 147: 1054-1059.
11. Henry DA, Dobson A, Turner C. Variability in the risk of major gasrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1077-1088.
12. Garcia Rodriguez LA, Walker AM, Perez Guttenhann S. Non-steroidal anti-inflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology 1992; 3: 337-342.
13. Weil J, Colin Jones D, Langman MJS, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830.
14. Rockall TA, Logan RFA, Devlin HV, Northfield TC. Incidence of and mortality from acute upper gastroin testinal haemorrhage in the United Kingdom. BMJ 1995; 311: 222-226.
15. Office of National Statistics Series DH5 no. 19.
16. Somerville K, Faulkner G, Langman M. Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; i: 462-464.
17. Armstrong CP, Blower AL. Nonsteroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987; 28: 527-532.
18. Davies HTO, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ 1998; 316: 989-990.
19. Henry D, Lim LL-Y, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996; 312: 1563-1566.
20. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastrointestinal haemorrhage in West of Scotland: case ascertainment study. BMJ 1997; 315: 510-514.
21. Henry DA, Johnston A, Dobson A, Duggan J. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. BMJ 1987; 295: 1227-1229.